Correlation Between Nouveau Life and Cloud DX
Can any of the company-specific risk be diversified away by investing in both Nouveau Life and Cloud DX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nouveau Life and Cloud DX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nouveau Life Pharmaceuticals and Cloud DX, you can compare the effects of market volatilities on Nouveau Life and Cloud DX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nouveau Life with a short position of Cloud DX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nouveau Life and Cloud DX.
Diversification Opportunities for Nouveau Life and Cloud DX
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Nouveau and Cloud is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nouveau Life Pharmaceuticals and Cloud DX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cloud DX and Nouveau Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nouveau Life Pharmaceuticals are associated (or correlated) with Cloud DX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cloud DX has no effect on the direction of Nouveau Life i.e., Nouveau Life and Cloud DX go up and down completely randomly.
Pair Corralation between Nouveau Life and Cloud DX
If you would invest 0.02 in Nouveau Life Pharmaceuticals on September 5, 2024 and sell it today you would lose (0.01) from holding Nouveau Life Pharmaceuticals or give up 50.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.46% |
Values | Daily Returns |
Nouveau Life Pharmaceuticals vs. Cloud DX
Performance |
Timeline |
Nouveau Life Pharmac |
Cloud DX |
Nouveau Life and Cloud DX Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nouveau Life and Cloud DX
The main advantage of trading using opposite Nouveau Life and Cloud DX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nouveau Life position performs unexpectedly, Cloud DX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cloud DX will offset losses from the drop in Cloud DX's long position.Nouveau Life vs. Manaris Corp | Nouveau Life vs. Green Planet Bio | Nouveau Life vs. Continental Beverage Brands | Nouveau Life vs. Opus Magnum Ameris |
Cloud DX vs. Caduceus Software Systems | Cloud DX vs. Cogstate Limited | Cloud DX vs. Cognetivity Neurosciences | Cloud DX vs. Mednow Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |